Members {#cesec1}
=======

CEACEACAM5, CD66eCEACAM1CD66a, Cell-CAM 105, BGP, biliary glycoprotein, NCA-160CEACAM3CD66d, CGM1CEACAM4CGM7CEACAM6CD66c, NCA, NCA-90, CGM6CEACAM7CGM2CEACAM8CD66b, CGM6, CGM8, NCA-95[^1]

Family {#cesec2}
======

Immunoglobulin superfamily

Structure {#cesec3}
=========

**Molecular weights**Amino acidsCEA702CEACAM1526CEACAM3252CEACAM6344CEACAM8349PolypeptideCEA76795CEACAM157560CEACAM327077CEACAM637161CEACAM838154SDS-PAGE reducedCEA180--200 kDaCEACAM1140--180 kDaCEACAM335 kDaCEACAM690--95 kDaCEACAM895--100 kDa**Carbohydrate***N*-linked sitesCEA28CEACAM120CEACAM32CEACAM612CEACAM811*O*-linked sites**Gene location**19q13.1--19q13.2**Gene structure**The CEA family comprises at least 28 separate genes.

Alternative forms {#cesec4}
=================

CEACAM1, CEACAM3 and CEACAM7 are alternatively spliced. The largest isoforms are shown here.

Structure {#cesec5}
=========

The human CEA family is part of a cluster of at least 28 genes divided into two functional groups. By genomic mapping, the CEACAM subgroup contains seven members and the PSG (pregnancy-specific glycoprotein) subgroup of secreted molecules contains 11 members. The remaining genes are thought to be pseudogenes[@bib1]. Within the best characterized CEACAM members, CEACAM1 and CEACAM3 encode type 1 transmembrane proteins while CEACAM8, CEACAM6 and CEA are GPI anchored in the membrane. All members possess an N-terminal V-type Ig domain followed by between 0 and 6 C2-type Ig domains. Apart from CEACAM3, the extracellular domains are extensively *N*-glycosylated. CEACAM1 and CEACAM3 have putative tyrosine phosphorylation sites in their cytoplasmic domains, which could bind signalling components such as the tyrosine phosphatases SHP-1 and SHP-2; CEACAM1 can associate with the cytoplasmic tyrosine kinases Src, Lyn and Hck[@bib3], [@bib4]. Alternative splicing results in CEACAM1, 3 and 7 isoforms with varying numbers of Ig domains and/or shorter cytoplasmic domains[@bib1]. Further structural and sequence information on other CEACAM family members and members of the PSG family can be found in [@bib1] and [@bib2].

Ligands {#cesec6}
=======

The CEACAM family can mediate homophilic cell--cell adhesion and in certain combinations, heterophilic interactions with other family members[@bib5]. Binding is via the V-type domain[@bib6], [@bib7]. In addition, CEACAM1 and CEACAM6 have been reported to bind E-selectin, CEACAM1 and CEACAM3 can act as a receptors for *Neisseria gonorrhoeae* and *Neisseria meningitidis* [@bib8], murine CEACAM1 and CEACAM2 are receptors for murine coronaviruses[@bib9], and CEACAM6 can bind galectins.

Function {#cesec7}
========

Binding assays indicate a role for CEACAM family members in mediating adhesion between granulocytes and/or between granulocytes and epithelial cells, and as microbial receptors. In addition, signalling via CEACAM1 and CEACAM3 cytoplasmic domains[@bib4] may regulate the adhesive activity of the β~2~ integrins[@bib10] and the cytolytic function of intraepithelial lymphocytes[@bib11]. Different splice variants of CEACAM1 and 3 display different bacterial tropism and invasion[@bib4]. Importantly, members of the CEACAM family are strongly down-regulated in malignancies, implicating these receptors as putative tumour suppressors[@bib4]. It should be noted that Cell-CAM 105 originally identified in rats and described as a homophilic adhesion molecule involved in the formation and maintenance of hepatocyte polarization and exhibiting ecto-ATPase activity[@bib12],[@bib13], is CEACAM1.

Distribution {#cesec8}
============

CEACAM1 and CEACAM6 are abundant on granulocytes and epithelial cells, CEACAM8 and CEACAM3 are restricted to granulocytes, and CEA is mostly found on epithelial cells.

Disease association {#cesec9}
===================

OMIM CEA, 114890; CEACAMl, 109770; CEACAM6, 163980.

CEACAM1 and CEA are strongly down-regulated in colon and other carcinomas. Evidence that CEACAM proteins can act as tumour suppressors comes from studies in which transfection of CEACAM1 in carcinoma cells resulted in an inhibition of tumour development in nude mice and conversely down-regulation in benign cells resulted in increased tumourigenicity[@bib4]. CEA levels in serum are used routinely as clinical markers in the diagnosis and serial monitoring of cancer patients for recurrent disease or response to therapy.

Knockout {#cesec10}
========

MGI:1347245 (CEACAM1)

Amino acid sequence of human CEA {#cesec11}
================================

In CEA the C-terminus is proteolytically cleaved and a GPI anchor attached. However, the site of cleavage has not been unambigously determined.

Amino acid sequence of human CEACAM1 {#cesec12}
====================================

Amino acid sequence of human CEACAM3 {#cesec13}
====================================

Amino acid sequence of human CEACAM6 {#cesec14}
====================================

The sequences sequences underlined and in italics are cleaved off to form mature CEACAM6 and a GPI anchor is added.

Amino acid sequence of human CEACAM8 {#cesec15}
====================================

The sequences sequences underlined and in italics are cleaved off to form mature CEACAM8 and a GPI anchor is added.

Database accession {#cesec16}
==================

*EMBL/GenBankSwissProt*CEAM17303P06731CEACAM1X16354P13688CEACAM3L00692P40198CEACAM6M29541P40199CEACAM8X52378P31997

[^1]: Note: The carcinoembryonic antigen (CEA) family nomenclature has recently been redefined[@bib1], [@bib2].
